Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $143
Merck & Co., Inc. -0.37% Post
Merck & Co., Inc. MRK | 109.77 109.60 | -0.37% -0.15% Post |
Truist Securities analyst Robyn Karnauskas maintains Merck & Co (NYSE:
MRK) with a Buy and raises the price target from $142 to $143.